Big Pharma slow to get the picture
At least that’s the view of Bain & Co partner Tim van Biesen, who told the Reuters Health Summit there were clear parallels between the revolution in photography and the looming slump in sales and profits as old blockbuster drugs face a cliff of patent expiries.
“Next month’s film sales were so overwhelmingly profitable that it was very hard to pull away from that business model. Pharma today is still faced with that same dilemma,” he said.
Click here to listen.